Pharmacological studies of methoxycarbonyl etomidate's carboxylic acid metabolite

Anesthesia and Analgesia

Volumn 115, Issue 2, 2012, Pages 305-308

  Ge, Ri Le ^a   Pejo, Ervin ^a   Haburcak, Marian ^a   Husain, S Shaukat ^a   Forman, Stuart A ^a   Raines, Douglas E ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; CARBOXYLIC ACID; ETOMIDATE; HYDROCORTISONE; METHOXYCARBONYL ETOMIDATE; UNCLASSIFIED DRUG;

ADRENAL CORTEX; ADRENAL CORTEX CELL; ANESTHESIA LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOASSAY; CONTROLLED STUDY; DRUG POTENCY; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; TADPOLE;

ADRENAL CORTEX; ANIMALS; BIOTRANSFORMATION; CARBOXYLIC ACIDS; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ETOMIDATE; GABA-A RECEPTOR AGONISTS; HUMANS; HYDROCORTISONE; HYPNOTICS AND SEDATIVES; LARVA; MEMBRANE POTENTIALS; RECEPTORS, GABA-A; REFLEX; XENOPUS LAEVIS;

EID: 84864402162     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ANE.0b013e318239c6ca     Document Type: Article

References (12)

1. Cotten JF, Husain SS, Forman SA, Miller KW, Kelly EW, Nguyen HH, Raines DE. Methoxycarbonyl-etomidate: a novel rapidly metabolized and ultra-short-acting etomidate analogue that does not produce prolonged adrenocortical suppression. Anesthesiology 2009;111:240-9
2. Westmoreland CL, Hoke JF, Sebel PS, Hug CC Jr, Muir KT. Pharmacokinetics of remifentanil (GI87084B) and its major metabolite (GI90291) in patients undergoing elective inpatient surgery. Anesthesiology 1993;79:893-903 (Pubitemid 23339046)
3. Hoke JF, Cunningham F, James MK, Muir KT, Hoffman WE. Comparative pharmacokinetics and pharmacodynamics of remifentanil, its principle metabolite (GR90291) and alfentanil in dogs. J Pharmacol Exp Ther 1997;281:226-32 (Pubitemid 27203072)
4. Shaffer JE, Quon CY, Gorczynski RJ. Beta-adrenoreceptor antagonist potency and pharmacodynamics of ASL-8123, the primary acid metabolite of esmolol. J Cardiovasc Pharmacol 1988;11:187-92 (Pubitemid 18045974)
5. Brosnan RJ, Pypendop BH, Siao KT, Stanley SD. Effects of remifentanil on measures of anesthetic immobility and analgesia in cats. Am J Vet Res 2009;70:1065-71
6. Kilpatrick GJ, McIntyre MS, Cox RF, Stafford JA, Pacofsky GJ, Lovell GG, Wiard RP, Feldman PL, Collins H, Waszczak BL, Tilbrook GS. CNS 7056: a novel ultra-short-acting benzodiaz-epine. Anesthesiology 2007;107:60-6 (Pubitemid 46987820)
7. Cotten JF, Le Ge R, Banacos N, Pejo E, Husain SS, Williams JH, Raines DE. Closed-loop continuous infusions of etomidate and etomidate analogs in rats: a comparative study of dosing and the impact on adrenocortical function. Anesthesiology 2011;115:764-73
8. Cotten JF, Forman SA, Laha JK, Cuny GD, Husain SS, Miller KW, Nguyen HH, Kelly EW, Stewart D, Liu A, Raines DE. Carboetomidate: a pyrrole analog of etomidate designed not to suppress adrenocortical function. Anesthesiology 2010;112: 637-44
9. Waud DR. On biological assays involving quantal responses. J Pharmacol Exp Ther 1972;183:577-607
10. Rusch D, Zhong H, Forman SA. Gating allosterism at a single class of etomidate sites on alpha1beta2gamma2L GABA A receptors accounts for both direct activation and agonist modulation. J Biol Chem 2004;279:20982-92 (Pubitemid 38656498)
11. Husain SS, Ziebell MR, Ruesch D, Hong F, Arevalo E, Kosterlitz JA, Olsen RW, Forman SA, Cohen JB, Miller KW. 2-(3-Methyl-3H-diaziren-3-yl)ethyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylate: a derivative of the stereoselective general anesthetic etomidate for photolabeling ligand-gated ion channels. J Med Chem 2003; 46:1257-65 (Pubitemid 36428231)
12. Rosenberg LS, Hostetler CK, Wagenknecht DM, Aunet DA. An accurate prediction of the pH change due to degradation: correction for a "produced" secondary buffering system. Pharm Res 1988;5:514-7